Return
Company Page
QuantX Biosciences is a privately held pharmaceutical company advancing oral small-molecule medicines through a computationally driven drug discovery platform. The company integrates physics-based modeling, statistical methods, and computational chemistry to rapidly design and optimize drug candidates against clinically validated targets. QuantX is focused on building a pipeline of differentiated therapies for immune-mediated and inflammatory diseases, with programs including STAT6 and IL-17 oral small molecule inhibitors.
Company Founded in 2022
Healthtech & Biotech